Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatment

• Désirée Gül,
• Oliver H. Krämer,
• Christoph Reinhardt

Affiliations

Désirée Gül

Molecular and Cellular Oncology, Department of Otorhinolaryngology Head and Neck Surgery, University Medical Center, Johannes Gutenberg-University Mainz

Oliver H. Krämer

Department of Toxicology, University Medical Center, Johannes Gutenberg-University Mainz

Christoph Reinhardt

Center for Thrombosis and Hemostasis (CTH), University Medical Center, Johannes Gutenberg-University Mainz